These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2866783)

  • 1. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
    Rigby JW; Scott AK; Hawksworth GM; Petrie JC
    Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative pharmacokinetics of beta-blockers].
    Kiechel JR; Meier J
    Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-blocker brain concentrations in man.
    Cruickshank JM; Neil-Dwyer G
    Eur J Clin Pharmacol; 1985; 28 Suppl():21-3. PubMed ID: 2865144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of the N-nitroso derivatives of six beta-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes.
    Robbiano L; Martelli A; Allavena A; Mazzei M; Gazzaniga GM; Brambilla G
    Cancer Res; 1991 May; 51(9):2273-9. PubMed ID: 1673086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol.
    Lennard MS; Tucker GT; Silas JH; Woods HF
    Xenobiotica; 1986 May; 16(5):435-47. PubMed ID: 2874665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
    Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
    Meier J
    Acta Med Scand Suppl; 1977; 606():65-70. PubMed ID: 19931
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
    Shand DG
    Drugs; 1974; 7(1):39-47. PubMed ID: 4151694
    [No Abstract]   [Full Text] [Related]  

  • 13. The new beta-adrenergic antagonists.
    Chung DC; Laschuk MJ
    Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
    [No Abstract]   [Full Text] [Related]  

  • 14. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
    Ravid M; Lang R; Jutrin I
    Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenoceptor blocker pharmacokinetics and the oral contraceptive pill.
    Kendall MJ; Jack DB; Quarterman CP; Smith SR; Zaman R
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):87S-89S. PubMed ID: 6146344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.
    Feely J
    Clin Pharmacokinet; 1983; 8(1):1-16. PubMed ID: 6132696
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
    Bradbrook ID; Babiker M; Crome P; Gillies HC; Morrison PJ; Rogers HJ; Shotton P
    Br J Clin Pharmacol; 1986 Apr; 21(4):371-6. PubMed ID: 3707811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
    Wilcox RG; Hampton JR
    Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
    Schneider RE; Bishop H; Kendall MJ; Quarterman CP
    Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and degradation products for direct photolysis of beta-blockers in water.
    Liu QT; Williams HE
    Environ Sci Technol; 2007 Feb; 41(3):803-10. PubMed ID: 17328186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.